Skip to content

In the BioHarmony Drug Report Database

Carvedilol

Coreg (carvedilol) is a small molecule pharmaceutical. Carvedilol was first approved as Coreg on 1995-09-14. It is used to treat angina pectoris, heart failure, hypertension, and myocardial infarction in the USA. The pharmaceutical is active against beta-2 adrenergic receptor and beta-1 adrenergic receptor. In addition, it is known to target beta-3 adrenergic receptor and ryanodine receptor 2.
Trade Name Coreg
Common Name Carvedilol
Indication angina pectoris, heart failure, hypertension, myocardial infarction
Drug Class Vasodilators (undefined group)
Carvedilol
Get full access now